See more : First National Bank Alaska (FBAK) Income Statement Analysis – Financial Results
Complete financial analysis of Fiore Cannabis Ltd. (FIORF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fiore Cannabis Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Cybertrust Japan Co., Ltd. (4498.T) Income Statement Analysis – Financial Results
- Mako Mining Corp. (MAKOF) Income Statement Analysis – Financial Results
- Northern Lights Acquisition Corp. (NLITW) Income Statement Analysis – Financial Results
- Blue Water Acquisition Corp. (BLUWU) Income Statement Analysis – Financial Results
- Branicks Group AG (DDCCF) Income Statement Analysis – Financial Results
Fiore Cannabis Ltd. (FIORF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://fiorecannabis.com
About Fiore Cannabis Ltd.
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in October 2020. The company was incorporated in 2007 and is headquartered in Kelowna, Canada.
Metric | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.15M | 2.27M | 1.46M | 0.00 | 383.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 2.44M | 1.72M | 888.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 711.00K | 549.00K | 572.00K | 0.00 | 383.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 22.57% | 24.21% | 39.18% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 5.76M | 9.46M | 21.49M | 17.40M | 9.89M | 2.50M | 255.65K | 56.56K | 52.10K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 924.00 | 20.27K | 0.00 | 0.00 | 0.00 |
SG&A | 5.76M | 9.46M | 21.49M | 17.40M | 9.89M | 2.50M | 275.92K | 56.56K | 52.10K | 0.00 |
Other Expenses | 0.00 | 0.00 | -702.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 6.44M | 10.19M | 22.32M | 17.69M | 10.15M | 2.51M | 276.49K | 56.56K | 52.10K | 0.00 |
Cost & Expenses | 8.88M | 11.91M | 23.21M | 17.69M | 10.15M | 2.51M | 276.49K | 56.56K | 52.10K | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.28M | 2.14M | 969.00K | 318.00K | 108.14K | 13.55K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.61M | 4.19M | 284.20K | 216.84K | 2.77K | 2.77K | 578.00 | -86.84K | 0.00 | 0.00 |
EBITDA | -4.91M | 5.13M | -17.90M | -18.10M | -9.66M | -2.50M | -275.92K | -143.40K | -52.10K | 0.00 |
EBITDA Ratio | -155.78% | 226.06% | -1,226.10% | 0.00% | -2,516.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -5.73M | -10.89M | -21.75M | -17.69M | -9.77M | -2.51M | -296.49K | -56.56K | -52.10K | 0.00 |
Operating Income Ratio | -181.94% | -480.16% | -1,489.73% | 0.00% | -2,544.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -376.00K | -25.49M | -6.63M | -2.73M | -111.87K | -775.34K | -4.35M | 86.84K | 0.00 | 0.00 |
Income Before Tax | -8.18M | -37.44M | -29.42M | -20.74M | -9.99M | -3.30M | -4.63M | 30.28K | -52.10K | 0.00 |
Income Before Tax Ratio | -259.65% | -1,650.84% | -2,015.27% | 0.00% | -2,601.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 125.00K | 765.00K | 710.00K | -763.00K | -3.73K | 13.55K | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -8.85M | -39.96M | -29.42M | -20.74M | -9.99M | -3.30M | -4.63M | 30.28K | -52.10K | 0.00 |
Net Income Ratio | -280.89% | -1,761.86% | -2,015.27% | 0.00% | -2,601.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.06 | -0.43 | -0.65 | -0.89 | -0.72 | -0.36 | -0.68 | 0.04 | -0.01 | 0.00 |
EPS Diluted | -0.06 | -0.43 | -0.65 | -0.89 | -0.72 | -0.36 | -0.68 | 0.04 | -0.01 | 0.00 |
Weighted Avg Shares Out | 152.18M | 93.96M | 45.52M | 23.17M | 13.87M | 9.15M | 6.83M | 790.82K | 8.84M | 0.00 |
Weighted Avg Shares Out (Dil) | 152.18M | 93.96M | 45.52M | 23.17M | 13.87M | 9.15M | 6.83M | 790.82K | 8.84M | 0.00 |
7 Penny Stocks With 10x Potential This Year
Fiore Cannabis Ltd. (FIORF) CEO Erik Anderson on Q3 2021 Result - Earnings Call Transcript
Fiore Cannabis Reports First Quarterly Net Profit, Focuses On U.S. Possible Federal Legalization
Fiore Cannabis Provides Corporate Updates Including Developments at Apex Cannabis Facility in Las Vegas
Fiore Cannabis Announces Second Quarter 2021 Financial Results As Company Projects Strong Performance in Second Half of the Year
Fiore Cannabis Completes Sale of Celista, B.C. Asset to Put Major Focus on Core U.S. Markets
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing
Fiore Cannabis Announces Debt Settlement Agreement To Further Strengthen Balance Sheet
Fiore Cannabis to Acquire California Cannabis Delivery Firm in $1.2 Million Transaction to Strengthen Market Focus
Fiore Cannabis Announces Expanded Product Portfolio for Nevada Market
Source: https://incomestatements.info
Category: Stock Reports